DAVID KNECHTEL: Open Payments
NPI 1932325750 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 29 payments from 11 companies in 2025. Trend: 2023 $396 · 2024 $625 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $175 |
| GENZYME CORPORATION | 4 | $90 |
| Insmed, Inc. | 3 | $78 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, Arikayce, TRELEGY ELLIPTA, ZERBAXA, OFEV, Ohtuvayre, YUPELRI.
Industry payments across TN — which companies pay providers there.
